Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: A randomized controlled trial

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 68, Issue 3, 2013, Pages 271-278

  Kersten, Hege ^a,b   Molden, Espen ^c,d   Tolo, Inga Kristin ^e   Skovlund, Eva ^c   Engedal, Knut ^a,c   Wyller, Torgeir Bruun ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b South Eastern Norway Regional Health Authority   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d DIAKONHJEMMET HOSPITAL   (Norway)

^e Center for Development of Institutional and Home Care Services   (Norway)

Author keywords

Adverse effects; Aged adults; Anticholinergic drugs; Clinical pharmacy; Cognition

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; BLOOD; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG USE; FEMALE; FRAIL ELDERLY; HUMAN; MALE; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; NURSING HOME; PHARMACIST; RANDOMIZED CONTROLLED TRIAL; RECALL; SALIVATION; SINGLE BLIND PROCEDURE;

AGED, 80 AND OVER; CHOLINERGIC ANTAGONISTS; COGNITION; DRUG UTILIZATION REVIEW; FEMALE; FRAIL ELDERLY; HUMANS; MALE; MENTAL RECALL; NEUROPSYCHOLOGICAL TESTS; NURSING HOMES; PHARMACISTS; SALIVATION; SINGLE-BLIND METHOD;

MLCS; MLOWN;

EID: 84873628373     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/gls176     Document Type: Article

References (40)

1. Tsilimingras D, Rosen AK, Berlowitz DR. Patient safety in geriatrics: a call for action. J Gerontol A Biol Sci Med Sci. 2003;58:M813-M819.
2. Hanlon JT, Pieper CF, Hajjar ER, et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. J Gerontol A Biol Sci Med Sci. 2006;61:511-515.
3. Flaherty JH, Perry HM 3rd, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci. 2000;55:M554-M559.
4. Onder G, Liperoti R, Fialova D, et al.; SHELTER Project. Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci. 2012;67:698-704.
5. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2012;60:616-631.
6. Chew ML, Mulsant BH, Pollock BG. Serum anticholinergic activity and cognition in patients with moderate-to-severe dementia. Am J Geriatr Psychiatry. 2005;13:535-538.
7. Wawruch M, Macugova A, Kostkova L, et al. The use of medications with anticholinergic properties and risk factors for their use in hospitalised elderly patients. Pharmacoepidemiol Drug Saf. 2012;21:170-176.
8. Peters NL. Snipping the thread of life. Antimuscarinic side effects of medications in the elderly. Arch Intern Med. 1989;149:2414-2420.
9. Nebes RD, Pollock BG, Halligan EM, Kirshner MA, Houck PR. Serum anticholinergic activity and motor performance in elderly persons. J Gerontol A Biol Sci Med Sci. 2007;62:83-85.
10. Chew ML, Mulsant BH, Pollock BG, et al. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc. 2008;56:1333-1341.
11. Mulsant BH, Pollock BG, Kirshner M, Shen C, Dodge H, Ganguli M. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry. 2003;60:198-203.
12. Fox C, Richardson K, Maidment ID, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. 2011;59:1477-1483.
13. Campbell N, Boustani M, Limbil T, et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging. 2009;4:225-233.
14. Halvorsen KH, Ruths S, Granas AG, Viktil KK. Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scand J Prim Health Care. 2010;28:82-88.
15. Gray SL, Sager M, Lestica MR, Jalaludin M. Adverse drug events in hospitalized elderly. J Gerontol A Biol Sci Med Sci. 1998;1:59-63.
16. Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46:1481-1486.
17. Marin DB, Flynn S, Mare M, et al. Reliability and validity of a chronic care facility adaptation of the Clinical Dementia Rating scale. Int J Geriatr Psychiatry. 2001;16:745-750.
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
19. National Kidney Foundation. Calculators for health care professionals. Available at http://www.kidney.org/professionals/kdoqi/gfr-calculator.cfm
20. Karrasch M, Sinervä E, Grönholm P, Rinne J, Laine M. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease. Acta Neurol Scand. 2005;111:172-179.
21. Braekhus A, Laake K, Engedal K. The Mini-Mental State Examination: identifying the most efficient variables for detecting cognitive impairment in the elderly. J Am Geriatr Soc. 1992;40:1139-1145.
22. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci. 1993;694:72-77.
23. Tune L, Coyle JT. Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch Gen Psychiatry. 1980;37:293-297.
24. Jakobsen SM, Kersten H, Molden E. Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a high-throughput radio receptor bioassay. J Am Geriatr Soc. 2011;59:501-505.
25. Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168:508-513.
26. Han L, Agostini JV, Allore HG. Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. J Am Geriatr Soc. 2008;56:2203-2210.
27. Fox C, Livingston G, Maidment ID, et al. The impact of anticholinergic burden in Alzheimer's dementia-the LASER-AD study. Age Ageing. 2011;40:730-735.
28. Bottiggi KA, Salazar JC, Yu L, et al. Long-term cognitive impact of anticholinergic medications in older adults. Am J Geriatr Psychiatry. 2006;14:980-984.
29. Kolanowski A, Fick DM, Campbell J, Litaker M, Boustani M. A preliminary study of anticholinergic burden and relationship to a quality of life indicator, engagement in activities, in nursing home residents with dementia. J Am Med Dir Assoc. 2009;10:252-257.
30. Carrière I, Fourrier-Reglat A, Dartigues JF, et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med. 2009;169:1317-1324.
31. Brébion G, Bressan RA, Amador X, Malaspina D, Gorman JM. Medications and verbal memory impairment in schizophrenia: the role of anticholinergic drugs. Psychol Med. 2004;34:369-374.
32. Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167:781-787.
33. Cao YJ, Mager DE, Simonsick EM, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther. 2008;83:422-429.
34. Hilmer SN, Gnjidic D, Abernethy DR. Pharmacoepidemiology in the postmarketing assessment of the safety and efficacy of drugs in older adults. J Gerontol A Biol Sci Med Sci. 2012;67:181-188.
35. Cancelli I, Gigli GL, Piani A, et al. Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study. J Clin Psychopharmacol. 2008;28:654-659.
36. Hilmer SN, Mager DE, Simonsick EM, et al.; Health ABC Study. Drug burden index score and functional decline in older people. Am J Med. 2009;122:1142-1149.e1.
37. Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ. 2006;332:455-459.
38. Lechevallier-Michel N, Molimard M, Dartigues JF, Fabrigoule C, Fourrier-Réglat A. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study. Br J Clin Pharmacol. 2005;59:143-151.
39. Uusvaara J, Pitkala KH, Kautiainen H, Tilvis RS, Strandberg TE. Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: A prospective study. Drugs Aging. 2011;28:131-138.
40. Hamilton HJ, Gallagher PF, O'Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatr. 2009;9:5.